Six detained for abuse of patients in Bulgaria nursing home
SOFIA, June 9 (Reuters) - Six people have been arrested in a Bulgarian village on suspicion of beating and drugging patients in a private nursing home for older people and those with dementia or other mental health problems, authorities said on Monday.
As elsewhere in Europe, incomes in Bulgaria have failed to keep pace with the rising costs of elderly and nursing care, and a few providers have exploited vulnerable patients with sub-standard or even abusive levels of care.
"The scariest thing we saw was people who were subjected to constant physical abuse - tied up, beaten, there is also evidence of drugging," Ivan Krastev, deputy minister of labour and social policy, told Nova TV.
On Friday, police raided a hospice with 75 residents in the central village of Yagoda, arresting five people on suspicion of mistreating patients and another on Sunday.
They are charged with unlawful imprisonment and obstruction of free movement, failure to provide due assistance to a person in danger, physical violence, and causing bodily harm, district prosecutor Tanya Dimitrova told reporters on Monday.
Eleven patients were taken to a nearby state hospital, while the remaining 64 were either taken in by relatives or accommodated in state-run facilities.
Bulgarian media reported that some patients had been found with their feet tied, under the influence of narcotics or locked in rooms without proper hygiene, bedding or contact with the outside world.
"They lock us up like dogs. They give us two slices of bread and in this heat they don't open the door to let air in, as they're afraid we'll escape," 70-year-old patient Milka Raeva told BTV TV.
"They were four very difficult years. God helped me. Many people died hungry, without doctors, with wounds, tied up."
Bulgarian media reported that the facility was charging 990 levs ($580) per month per room. Another illegal nursing home in Govedartsi with 23 patients was closed down on Monday.
($1 = 1.7104 leva)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
34 minutes ago
- The Sun
The 52p herb that could help prevent Alzheimer's – plus 3 other ways it can benefit your health
KNOWN for its strong, pine-like flavour and its use in various dishes, rosemary has a lot more going for it than its scent and taste. The popular herb is starting to gain recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. And research published this year suggests it could even help in the fight against Alzheimer's disease - the leading cause of dementia worldwide. Rosemary has previously been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary to sharpen concentration and recall, says Dipa Kamdar, senior lecturer in pharmacy practice at Kingston University. Writing for The Conversation, she explains: "Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory takes compared to those in an unscented environment." There are several ways rosemary benefits the brain, says Kamdar. Firstly, it stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties, with some studies suggesting its aroma can reduce anxiety and improve sleep - lower stress means better focus and memory retention. Kamdar adds: "Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age." And rosemary's antioxidants may also help protect brain cells from damage caused by oxidative stress - which is a major factor in cognitive decline. Kamdar says: " Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease." Five simple tests that could indicate dementia What are rosemary's benefits beyond brain health? 2 As well as boosting brain health, studies suggest rosemary may aid digestion by stimulating the liver to produce bile, which helps the body digest fat. In a study with mice, it was shown to reduce inflammation in the digestive tract, potentially aiding in the management of IBS and other inflammatory bowel ailments. And rosemary supplementation may also positively impact the gut microbiota, increasing beneficial bacteria like Bifidobacterium and Bacteroidetes, while reducing harmful bacteria like Escherichia coli. Rosemary may also be able to improve immune function. Some studies, particularly in vitro and animal models, suggest that rosemary and its active compounds, like carnosic acid and rosmarinic acid, can influence immune function. Other studies have shown rosemary may promote immune cell activity, such as increasing antibody production or enhancing the activity of immune cells like dendritic cells. Finally, rosemary could prevent certain cancers. lung, prostate, liver, and breast. Carnosic acid appears to be the plant's primary anticancer component, as it was found in one study to exhibit antiproliferative effects in cancer cells. Compared to speciality herbs or spices, rosemary is considered a relatively affordable herb - just 52p for a 20g packet from Sainsbury's. Other ways to reduce your Alzheimer's risk Be physically active Regular physical activity is crucial for overall health and may help reduce the risk of dementia, including Alzheimer's disease. Aim for at least 150 minutes of moderate-intensity activity per week. Eat a healthy diet A balanced diet, potentially including the Mediterranean diet, can help reduce your risk of dementia, as well as other health conditions. Stay mentally active Keeping your mind active can strengthen your brain's ability to cope with disease. Engage in activities like reading, learning new skills, or playing brain games. Manage other health conditions Maintaining healthy blood pressure, cholesterol, and blood sugar levels can also contribute to reducing your risk of dementia. Prioritise sleep Aim for seven to eight hours of quality sleep each night, as sleep deprivation can negatively impact brain health. Maintain good heart health Taking care of your heart health, including avoiding smoking and excessive alcohol consumption, can also lower your risk of dementia and other diseases. Seek medical advice If you have any concerns about your health or a family history of Alzheimer's, consult with a healthcare professional.
Daily Mail
38 minutes ago
- Daily Mail
Why living until you're 200 really isn't a pipe dream
The idea of living for hundreds of years was once thought to be the pipe dream of billionaires and tech moguls. But scientists at the forefront of anti-ageing research believe they are on the cusp of developing a pill that could lead to people living to the age of 200 and beyond. Medical advances in the last century have led to humans in wealthy nations living into their 80s, almost double the average life expectancy at the turn of the 20th century. Improved nutrition, clean water, better sanitation and huge leaps in medicine have been key in prolonging human life. The oldest known person — the Frenchwoman Jeanne Calment, who sold canvases to Vincent Van Gogh when she was a girl in the late 1800s — lived to the age of 122, dying in 1997. There is some debate about whether humans can naturally live much beyond that age, but it is hoped that science will take human lifespans beyond what is currently thought possible. Dr Andrew Steele, a British computational biologist and author of a new book on longevity, told MailOnline there is no biological reason humans can't reach the age of 200. He believes the big breakthrough will come in the form of drugs that remove 'zombie cells' in the body, which are thought to be one of the main culprits of tissue and organ decay as we age. Pills that flush these cells out of the body are already in human trials in and could be on the market in as little as 10 years, according to Dr Steele, who believes someone reading this could make it to 150 with the help of the drugs. Another field in particular that piques the interest of anti-ageing scientists is the study of DNA of reptiles and other cold-blooded animals. Michigan State University experts have begun studying dozens different types of long-living reptiles and amphibians — including crocodiles, salamanders and turtles that can live as long as 120 years. The team hope they will uncover 'traits' that can also be targeted in humans. Some experts think that eradicating the big killers — cancer, dementia and heart disease — could be the true key to longevity. Dr Steele, the author of Ageless: The New Science of Getting Older Without Getting Old, told MailOnline: 'I don't think there is any kind of absolute cap on how long we can live. 'Studies come out every few years that propose some kind of fundamental limit on human lifespan, but they're always missing one crucial piece: we've never tried treating the ageing process before. 'I can't see physical or biological reason why people couldn't live to 200 — the challenge is whether we've can develop the biomedical science to make it possible.' Other experts believe humans could live to 150 naturally, if it wasn't for chronic illnesses, including Dr Peter Fedichev, a Russian molecular physicist who runs a biomedical AI firm Gero. His company has been studying the genetic data of 500,000 Britons in pursuit of the firm's goal of 'hacking ageing', as they call it. Researchers at Gero made use of an instrument, called DOSI (dynamic organism state indicator), that takes into account age, illness and lifestyle factors, to work out how resilient the body is, including its ability to recover from injury or disease. Using mathematical models, it calculated the maximum age the body — if not altered by drugs or gene therapy — can still recover from is between 120 and 150. The findings were revealed in a study published in the journal Nature Communications last year. But Dr Fedichev warned life extension without improving life quality would be pointless because extremely elderly people would be frail, and prone to illness, meaning new drugs will be vital in the quest for eternal youth. He told MailOnline: 'Such life extension would increase their lifespan past the end of their health span and thus reduce their quality of life. 'Only addressing the root causes of ageing may help bring humans closer to negligibly senescent animals, intercept aging and increase our productive lifespan by a hundred years or more. 'That is why we are calling on a refocusing of our attention from diseases to ageing, from incremental to more radical solutions using those slow-aging animals as inspiration.' Dr Steele says new advances in senolytics could extend life span and quality. Senescent cells — dubbed 'zombie cells' — are cells that eventually stop dividing, then accumulate, releasing compounds in the body that accelerate ageing. Experts believe younger people with healthy immune systems are better able to clear the damaged cells, but as people age, they aren't removed as effectively and they accumulate causing potential problems. Dr Steele said if you put a human cell in a petri dish, it would divide around 50 times before stopping, whereas a Galapagos tortoise — which can live for up to 120 years — sees its cells divide more than 100 times. Studying these sorts of long-living reptiles can help researchers understand more about the way human cells age. Since the 1960s, scientists have known that, as we age, we accumulate ever-greater numbers of these cells, but it wasn't clear if they were just a product of ageing or whether they caused it. The breakthrough came in 2016 when scientists found removing the cells from mice, typically with a short lifespan and plagued with a range of age-related conditions, by injecting them with a synthetic drug called AP20187 extended their life by up to 35 per cent — suggesting senescence was behind ageing itself. Since then, there have been a number of studies confirming the importance of such cells in the ageing process. In 2019, research in the journal Aging Cell showed that old mice pre-treated with Navitoclax, an experimental anti-cancer drug that kills senescent cells, recovered at similar rates to younger mice from an induced heart attack, raising the prospect of a new type of treatment for people with heart conditions. Another study, published in the journal EMBO, demonstrated that clearing out senescent cells from the hearts of mice also reduced symptoms of ageing, such as enlargement and thickening of the walls of the heart muscles. Senolytic drugs are now being safety tested in humans and have attracted investment from several billionaires, including Amazon founder Jeff Bezos and PayPal co-founder Peter Thiel. Dr Steele said: 'Scientists have given these drugs to mice, and they basically get biologically younger: they live longer, get less cancer and heart disease, are less frail — they can run further and faster on the tiny mouse-sized treadmills used in these experiments — and, honestly, they just look great, with plumper skin and thicker fur. 'What this shows us is that tackling the hallmarks of ageing can affect the whole ageing process, from disease risk to the cosmetic stuff, and can do so preventatively — this is the holy grail of anti-ageing medicine.' Both Bezos and Thiel are investors in Unity Biotechnology, which carried out the first human trial of one such drug, aimed at tackling moderate-to-severe osteoarthritis of the knee, in 2019. In the phase one trial, 78 patients were divided into two groups: one was given a dummy drug, while the other was injected in the knee with a drug codenamed UBX0101, which interferes with two proteins in the body, leading to the elimination of senescent cells. The study was a success, with UBX0101 'well-tolerated' by the treated patients, who, after a single injection, had experienced 'improvement in several clinical outcomes, including pain and function'. However, the company faced a setback in 2020 when results from the bigger phase 2 trial found no statistically significant difference between UBX0101 and the placebo groups. Now, the company is trialling a new drug called UBX1325, which has been designed to combat age-related blindness on 46 adults. Dr Steele said it only took one trial to be a success to make a breakthrough in the field of anti-ageing. He told MailOnline: 'We might get unlucky and none of this works but, if it does, every development gives us longer to make the next one, and the first 150-year-old could be someone who's reading this.' Last week, Michigan State University researchers announced they are studying 77 reptiles and amphibians with the hope of understanding what allows them to be so resilient. But they have yet to pinpoint any potential longevity targets, meaning a true breakthrough could still be years off. Dr Alex Zhavoronkov, a biotechnology expert and physicist, said studying animals — particularly those as distantly related to humans as reptiles — has rarely resulted in breakthroughs. He believes scientists are better placed focusing their efforts on studying ageing in real people, and, in particular, technology. Implant chips that use electrodes in the brain to ward off illnesses like Parkinson's are currently being trialled on people. Southmead Hospital in Bristol is believed to be the first in the world to implant the tiny deep brain stimulation (DBS) device when it launched its trial in April. The device works by delivering electrical impulses to damaged areas of the brain. Dr Zhavoronkov said: 'Many years from now humans will be able to control the biology of aging and many other converging technologies will not only return the lost functions but likely augment our capabilities — as you have seen with the glasses, cars, cell phones, the internet, and robotics. 'Advanced technologies starting from dual-purpose pharmaceuticals — drugs that target fundamental aging pathways and age-associated diseases and are trackable with aging biomarkers, which my team is focusing on— to cell and gene therapy and advances in regenerative medicine, implantables, and augmentation of human function with AI and robotics will allow us to dramatically increase life.
BreakingNews.ie
an hour ago
- BreakingNews.ie
Coroner warns people may not realise severity of burn injuries after death of Cavan farmer (79)
A coroner has warned that people may not realise the severity of burn injuries in some cases, after hearing about the death of an elderly Cavan man after a stick fell out of a wood-burning stove in his home. Patrick Lynch (79), a retired farmer of Cormore, Arva, Co Cavan, died as a result of complications of burn injuries at St James's Hospital in Dublin on August 29th, 2023. Advertisement A sitting of Dublin District Coroner's Court heard a neighbour of Mr Lynch had discovered a smouldering stick in a smoke-filled room when he called to see the deceased around 1:15pm on August 26th, 2023. Ciaran Ellis told an inquest into Mr Lynch's death that he rang an ambulance after discovering his neighbour lying crossways on a bed with his feet 'red with burns.' Mr Ellis said a stick that seemed to have fallen out of a door at the front of the stove was still smouldering on the floor. He recalled that the deceased's pyjamas and part of a chair were also burnt, although there was no evidence of a large fire of any type. Advertisement When asked how he felt, Mr Ellis said Mr Lynch had replied that he was not in any pain. 'He did not realise he was badly burnt,' said Mr Ellis. He said the deceased only complained about feeling a little bit of pain a few hours later, just before an ambulance arrived at around 4:30pm. The coroner, Cróna Gallagher, said some people with burn injuries did not appreciate the severity of their burns as they did not feel any pain because the injuries were so bad that nerve endings in their body had been damaged. Advertisement 'People with less severe burn injuries may feel far worse pain,' said Dr Gallagher. She observed that people with severe burn injuries might not seek the urgent treatment that they needed due to the misconception that the lack of pain indicated they were not badly hurt. 'It's a common issue that the part that is burnt can just look red, which means people think it might not be serious,' said Dr Gallagher. In reply to questions from the coroner, Mr Ellis said he would check on his neighbour two to three times per day. Advertisement He explained the deceased had moved his bedroom downstairs to the living room a few years previously because of his mobility issues. Mr Ellis also said his neighbour used the stove as his main source of heating and would be in the habit of packing it with wood. The deceased's brother, Jimmy Lynch, who gave evidence of formally identifying his brother's body to gardaí at St James's Hospital, said his brother had lived alone for over 25 years. While the deceased had a few health problems, including poor eyesight, Mr Lynch said his brother was able to manage, although he had not really left his house for a number of years. Advertisement Mr Lynch said he was never aware of any problem that his brother, who was a non-smoker, had with the stove. Sergeant Cathal Buggy gave evidence of examining the scene of the fatal incident and being satisfied that there was nothing suspicious about what happened. Sgt Buggy also confirmed that there was nothing defective with the stove. In a written statement, a paramedic, Billy Bushnell, said the initial triaging from the call for assistance had assessed Mr Lynch as a 'low priority' case. Mr Bushnell said the injured man was chatty and responsive to paramedics after the ambulance arrived at his house at 4:28pm. He said Mr Lynch had some third-degree burns and massive blistering on his legs, although he had stated that the pain was 'not too bad.' Mr Bushnell said he advised his controllers that the patient should be brought to St James's Hospital in Dublin, where the National Burns Unit is based, but was instructed to take him to Cavan General Hospital. He said he phoned ahead to the hospital in Cavan to have a resus team on standby, but none was in place by the time they arrived. The inquest heard Mr Lynch was transferred to St James's Hospital the following morning. Medical records showed he suffered burns to approximately 30 per cent of his body, which mostly related to his lower limbs. Doctors in St James's assessed him as requiring immediate surgery for full-thickness burns, as it was a life-threatening situation. However, they subsequently assessed that he would not survive further surgery, and his treatment was switched to palliative care. Dr Gallagher observed that it was not clear if it would have made any difference if Mr Lynch had received treatment sooner, although she believed it was 'unlikely". The results of a postmortem showed he had died as a result of complications of burns from material from a wood-burning stove, with heart disease as a contributory factor. Offering her sympathy to Mr Lynch's relatives, the coroner recorded a verdict of accidental death.
